Ansys and NVIDIA enhance cardiovascular research with AI

PITTSBURGH – Ansys (NASDAQ: ANSS), a technology company with a market capitalization of $28.3 billion and impressive gross profit margins of 92%, has announced a new collaboration with NVIDIA aimed at advancing cardiovascular research by integrating artificial intelligence (AI), simulation, and visualization technologies. This partnership focuses on making high-fidelity simulation more accessible, particularly in the healthcare sector. According to InvestingPro data, Ansys maintains a strong financial health score, positioning it well for innovative ventures.

The initiative was highlighted at the NVIDIA GTC event in San Jose, CA, showcasing how the technology can aid clinicians in analyzing heart anatomies with greater detail, which may lead to improved patient outcomes. The open-source technology framework, which includes the "PyAnsys-Heart" Python library, allows for the creation of partial and whole heart models within Ansys LS-Dyna® simulation software. The company’s solid performance, with 12.11% revenue growth in the last twelve months, supports its continued investment in innovative technologies.

Furthermore, NVIDIA’s NIM™ microservices and Ansys’s AI-based speech-to-text code generator facilitate the rendering of photorealistic simulation results for both experts and non-experts. This is achieved through the use of NVIDIA Omniverse, a platform for building and operating metaverse applications.

Dr. Francis Bessiere, a cardiac electrophysiologist, expressed optimism about the potential of these computational technologies to anticipate complex cases in cardiac care, enabling better preparation and treatment strategies.

In addition to healthcare applications, the collaboration will also support NVIDIA’s Isaac for Healthcare AI robotics platform, combining Ansys’s simulation tools to advance robotic and autonomous systems in medical settings.

Ansys’s chief technology officer, Prith Banerjee, emphasized the company’s commitment to innovation and making simulation tools more widely available across organizations. Rev Lebaredian, vice president of Omniverse and simulation technology at NVIDIA, echoed this sentiment, highlighting the role of GPU computing and physical AI in the future of personalized healthcare.

The announcement is based on a press release statement and marks a significant step towards democratizing simulation technology for broader use in the medical field and beyond. With five analysts recently revising their earnings expectations upward, Ansys appears well-positioned for future growth. For more detailed financial analysis and additional insights, including 13 more ProTips, visit InvestingPro.

In other recent news, Ansys has reported significant developments, including a robust fourth-quarter performance that exceeded expectations. The company’s revenue for Q4 increased by 10% year-over-year, reaching $882.2 million, surpassing forecasts. Operating margins also exceeded expectations, coming in at 53%. Analysts from Citi and Rosenblatt Securities have adjusted their price targets for Ansys, with Citi raising it to $371 and Rosenblatt to $340, both maintaining a Neutral rating.

Moreover, the UK competition regulator has approved Synopsys’ $35 billion acquisition of Ansys, following the companies’ agreement to certain remedies. This acquisition is anticipated to expand Synopsys’ product offerings. Ansys is also set to enhance its simulation software by integrating NVIDIA Omniverse, which aims to streamline simulation workflows and improve engineering insights across various industries. Additionally, Ansys has partnered with Concepts NREC to integrate computational fluid dynamics software into the turbomachinery design process, promising to shorten design cycles and enhance performance.

These developments reflect Ansys’s ongoing commitment to innovation and its strategic collaborations to enhance its technological offerings. The anticipated acquisition by Synopsys is expected to be completed in the first half of 2025, and it includes both cash and stock components. The integration with NVIDIA Omniverse is scheduled to begin in Q3 2025, indicating a forward-looking approach to maintaining competitive advantages in the market.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.